125173-90-2

Upstream product

• 555-21-5 4-Nitrophenylacetonitrile 
• 108-94-1 cyclohexanone 
• 38968-78-4 2-(4'-nitro)benzoylcyclohexanone 
• 6048-20-0 4-nitrobenzoyl cyanide 
• 125173-89-9 methyl 7-<4-phenyl>heptanoate 
• 125173-87-7 methyl 7-(4-nitrophenyl)heptanoate 
• 125173-88-8 7-(4-Amino-phenyl)-heptanoic acid methyl ester 
• 66147-99-7 7-(4-nitrophenyl)heptanoic acid 

Downstream Products

• 1236199-57-7 C₁₇H₂₆Cl₂N₂O₂ 
• 125173-75-3 Acridin-9-yl-(6-{4-[bis-(2-chloro-ethyl)-amino]-phenyl}-hexyl)-amine 
• 125173-91-3 [4-(6-Amino-hexyl)-phenyl]-bis-(2-chloro-ethyl)-amine 
• 159277-34-6 2-(6-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-hexyl)-3H-benzoimidazole-5-carbonitrile 
• 159277-33-5 7-(4-(N,N-bis(2-chloroethyl)amino)phenyl)heptanal 
• 1027573-11-0 7-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-heptan-1-ol 

Relevant academic research and scientific papers

HYDROXAMIC ACID DERIVATIVES

The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.

DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: Consequences of varying the reactivity of the mustard

A series of DNA-targeted aniline mustards have been prepared, and their chemical reactivity and in vitro and in vivo cytotoxicity have been evaluated and compared with that of the corresponding simple aniline mustards. The alkylating groups were anchored